Windward Private Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Hold
1,500
0.12% 34
2025
Q4
$361K Hold
1,500
0.13% 34
2025
Q3
$411K Hold
1,500
0.14% 32
2025
Q2
$387K Hold
1,500
0.14% 32
2025
Q1
$336K Hold
1,500
0.13% 34
2024
Q4
$343K Hold
1,500
0.13% 36
2024
Q3
$366K Hold
1,500
0.14% 39
2024
Q2
$287K Hold
1,500
0.12% 40
2024
Q1
$297K Hold
1,500
0.12% 40
2023
Q4
$258K Hold
1,500
0.11% 44
2023
Q3
$222K Hold
1,500
0.1% 45
2023
Q2
$328K Hold
1,500
0.15% 42
2023
Q1
$328K Hold
1,500
0.14% 41
2022
Q4
$312K Hold
1,500
0.14% 43
2022
Q3
$327K Hold
1,500
0.16% 44
2022
Q2
$314K Hold
1,500
0.14% 41
2022
Q1
$364K Hold
1,500
0.15% 41
2021
Q4
$391K Hold
1,500
0.15% 39
2021
Q3
$395K Hold
1,500
0.16% 39
2021
Q2
$370K Hold
1,500
0.15% 39
2021
Q1
$291K Hold
1,500
0.13% 44
2020
Q4
$319K Buy
+1,500
New +$299K 0.15% 41

Other funds holding RMD

Windward Private Wealth Management's RMD Position: Q1 2026 in Review

Windward Private Wealth Management held its ResMed (RMD) position steady in Q1 2026 at 1,500 shares worth $337K. The position accounts for 0.12% of the portfolio, ranked #34.

Windward Private Wealth Management first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $411K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Windward Private Wealth Management held 1,500 shares of ResMed worth $337K as of Q1 2026.
  • Windward Private Wealth Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.12% of Windward Private Wealth Management's portfolio in Q1 2026, its #34 holding.
  • Windward Private Wealth Management first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
  • Windward Private Wealth Management's ResMed position peaked at $411K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Windward Private Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.